WINTON GROUP Ltd bought a new position in Versigent (NYSE:VGNT - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 199,883 shares of the company's stock, valued at approximately $8,397,000. WINTON GROUP Ltd owned 0.28% of Versigent as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also bought and sold shares of VGNT. California State Teachers Retirement System purchased a new position in shares of Versigent in the second quarter valued at about $143,056,000. Allianz Asset Management GmbH purchased a new stake in shares of Versigent during the second quarter worth about $20,602,000. Steamboat Capital Partners LLC bought a new stake in Versigent during the 2nd quarter valued at approximately $10,385,000. Nan Shan Life Insurance Co. Ltd. bought a new stake in Versigent during the 2nd quarter valued at approximately $5,400,000. Finally, Ancora Advisors LLC purchased a new position in Versigent in the 2nd quarter worth approximately $4,197,000.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $54.00 price target on shares of Versigent in a research note on Wednesday, August 5th. Fox Advisors cut shares of Versigent from an "overweight" rating to an "equal weight" rating in a research report on Wednesday, August 5th. TD Cowen boosted their target price on shares of Versigent from $49.00 to $58.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. Oppenheimer set a $50.00 target price on shares of Versigent in a research report on Tuesday, July 21st. Finally, Wells Fargo & Company raised their target price on shares of Versigent from $48.00 to $56.00 and gave the company an "overweight" rating in a research note on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Versigent has a consensus rating of "Moderate Buy" and an average target price of $54.00.
View Our Latest Stock Analysis on VGNT
Versigent Trading Down 3.6%
NYSE:VGNT opened at $45.67 on Thursday. The company has a quick ratio of 1.09, a current ratio of 1.40 and a debt-to-equity ratio of 7.29. The stock has a market capitalization of $3.23 billion and a P/E ratio of 23.78. Versigent has a 12 month low of $26.34 and a 12 month high of $50.88. The stock has a 50-day moving average price of $44.16.
Versigent (NYSE:VGNT - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.34. The firm had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.29 billion. On average, research analysts forecast that Versigent will post 7.23 earnings per share for the current year.
Versigent Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be given a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, September 4th.
About Versigent
(
Free Report)
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Read More
Want to see what other hedge funds are holding VGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versigent (NYSE:VGNT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Versigent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.
While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.